Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis

Clinical trial NCT03373877 · TERMINATED

Trial details

NCT number: NCT03373877
Sponsor: Samus Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelofibrosis Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis

Start date: 2018-05-24
Primary completion: 2019-10-17
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.